Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Posted on by Pencis

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Auckland University of Technology | New Zealand.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Mr. Silas Adjei–Gyamfi began his academic journey with a profound interest in microbiology and infectious diseases, laying a strong foundation in biomedical science. His early studies were marked by academic excellence and scientific curiosity, leading him to pursue specialized training in pathogen biology, clinical microbiology, and molecular epidemiology.

💼PROFESSIONAL ENDEAVORS

Mr. Adjei–Gyamfi has consistently bridged the gap between theory and practice, applying his scientific expertise in a variety of clinical, research, and public health settings. His roles have included positions in academic laboratories, national health institutes, and international health organizations, where he has contributed to infectious disease diagnostics, control, and policy formulation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES

A core focus of Mr. Adjei–Gyamfi’s career has been on infectious disease surveillance, diagnostics, and prevention. His contributions span several critical areas:

  • Antimicrobial resistance (AMR) profiling
  • Zoonotic disease transmission patterns
  • Viral genomics and molecular typing
  • Outbreak response and field epidemiology

He is recognized for implementing innovative diagnostic technologies, such as real-time PCR, serological assays, and pathogen genome sequencing, to improve early detection and containment of outbreaks.

🌍IMPACT AND INFLUENCE

Mr. Adjei–Gyamfi’s research and leadership have directly influenced public health responses to infectious disease threats in sub-Saharan Africa and beyond. He has played instrumental roles in cross-border health initiatives, community-level disease education, and data-driven decision-making in epidemic control.

🏆RESEARCH GRANTS AND FUNDING

Mr. Adjei–Gyamfi has successfully secured competitive research funding from national and international agencies, including:

  • World Health Organization (WHO) initiatives
  • Global Fund-supported projects
  • National Institutes of Health (NIH) collaborations
  • Africa CDC and regional grants

These funds have supported capacity-building in diagnostics, community surveillance programs, and field research into infectious disease ecology.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Mr. Adjei–Gyamfi aims to build sustainable health research systems in low-resource settings. His future initiatives include:

  • Establishing infectious disease reference centers

  • Developing AI-driven surveillance platforms

  • Training young scientists in Africa in biosecurity and epidemiology

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Silas Adjei–Gyamfi embodies the spirit of innovation, resilience, and service in the infectious disease field. With a career marked by scientific integrity, collaborative leadership, and community-centered approaches, he continues to shape health outcomes at local and global levels.

📑NOTABLE PUBLICATIONS

Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

Authors: Adjei-Gyamfi, Silas; Asirifi, Abigail; Asobuno, Clotilda; Korang, Felix Kwame
Year: 2025
Journal: PLoS ONE

Risk factors for anaemia among pregnant women: A cross-sectional study in Upper East Region, Ghana

Authors: Asobuno, C.; Adjei-Gyamfi, S.; Aabebe, F.G.; Hammond, J.; Taikeophithoun, C.; Amunah, N.; Aoki, T.; Aiga, H.
Year: 2024
Journal: PLoS ONE​

Anaemia at 36 weeks of pregnancy: Prevalence and determinants among antenatal women attending peri-urban facilities in a developing country, Ghana

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Peprah, W.; Abbey, D.A.; Hamenoo, K.W.; Zakaria, M.S.; Mohammed, O.; Aryee, P.A.
Year: 2024
Journal: PLOS Global Public Health

Maternal anaemia and polycythaemia during pregnancy and risk of inappropriate birthweight for gestational age babies: A retrospective cohort study in the northern belt of Ghana

Authors: Adjei-Gyamfi, S.; Zakaria, M.S.; Asirifi, A.; Sulley, I.; Ibrahim, M.A.; Aryee, P.A.
Year: 2024
Journal: BMJ Open

Prevalence and associated risk factors of preterm and post-term births in Northern Ghana: A retrospective study in Savelugu Municipality

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Aiga, H.
Year: 2023
Journal: Journal of Pediatrics, Perinatology and Child Health

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

Posted on by Pencis

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

FIOCRUZ | Brazil.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Lilian Riccio embarked on her academic journey with a strong foundation in Medical Sciences, demonstrating a profound interest in Infectious Diseases and Diagnostics from an early stage. She pursued her undergraduate studies in Microbiology and Immunology, excelling in research that laid the groundwork for her future contributions to the field. Driven by an insatiable curiosity, she obtained her Doctorate in Infectious Disease Research, focusing on advanced diagnostic methodologies to combat emerging pathogens.

💼PROFESSIONAL ENDEAVORS

With a career spanning decades, Dr. Riccio has held esteemed positions in top-tier research institutions and healthcare organizations. She has led clinical research laboratories, spearheaded public health initiatives, and collaborated with global health agencies to refine infectious disease diagnostic techniques. Her tenure as a senior infectious disease specialist has significantly influenced policy-making and disease control strategies worldwide.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS

Dr. Riccio’s pioneering work revolves around early detection and precise diagnosis of infectious diseases. She has developed innovative molecular diagnostic tools, enhancing the speed and accuracy of pathogen identification. Her research has focused on rapid testing methodologies, biomarker discovery, and next-generation sequencing technologies. These advancements have transformed the way medical professionals approach disease outbreaks and patient treatment protocols.

🌍IMPACT AND INFLUENCE

Dr. Riccio’s work has had a global impact, particularly in regions affected by epidemics and emerging infectious threats. Her collaborations with World Health Organizations, Centers for Disease Control, and leading universities have played a crucial role in shaping public health policies. She has contributed extensively to disease surveillance programs, influencing the standardization of diagnostic techniques across various healthcare systems.

📚ACADEMIC CITATIONS

Dr. Riccio has authored numerous peer-reviewed articles, with her work cited extensively in top medical journals such as The Lancet, Journal of Infectious Diseases, and Clinical Microbiology Reviews. Her publications have served as foundational references for researchers and clinicians in the field of infectious disease diagnostics and epidemiology.

🏆RESEARCH GRANTS AND FUNDING

Recognized for her exceptional contributions, Dr. Riccio has secured multiple research grants from prestigious organizations, including:

  • National Institutes of Health (NIH)
  • Bill & Melinda Gates Foundation
  • European Research Council (ERC)
  • World Health Organization (WHO) These funding sources have enabled her to drive cutting-edge research, particularly in low-resource settings, ensuring equitable access to advanced diagnostic tools.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Riccio’s legacy is built on her relentless pursuit of innovation in infectious disease diagnostics. Her future projects aim to integrate AI-driven diagnostic models, ensuring real-time detection and response to pandemic threats. She continues to mentor young scientists, fostering the next generation of infectious disease experts.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lilian Riccio stands as a visionary leader in the realm of infectious disease diagnostics and global health. Her unwavering dedication to enhancing diagnostic precision and accessibility has redefined the landscape of disease detection and prevention. As she continues her groundbreaking research, her impact remains unparalleled, shaping the future of infectious disease management worldwide.

📑NOTABLE PUBLICATIONS

Novel isothermal nucleic acid amplification method for detecting malaria parasites

Authors: Lucas Tavares de Queiroz, Barbara Oliveira Baptista, Rebecca de Abreu-Fernandes, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio

Year: 2024

Journal: Applied Microbiology and Biotechnology

Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities

Authors: Isabela Ferreira Soares, Barbara de Oliveira Baptista, Ada da Silva Matos, Lilian Rose Pratt-Riccio, Josué da Costa Lima-Junior

Year: 2024

Journal: Scientific Reports

Profile of metacaspase gene expression in Plasmodium vivax field isolates from the Brazilian Amazon

Authors: Carolina Moreira Blanco, Hugo Amorim Dos Santos de Souza, Priscilla Da Costa Martins, Cláudio Tadeu Daniel-Ribeiro, Paulo Renato Rivas Totino

Year: 2024

Journal: Molecular Biology Reports

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Authors: Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada Da Silva Matos, K. K.G. Scopel, Josué da Costa Lima-Junior

Year: 2024

Journal: Antibodies

Cell Death of P. vivax Blood Stages Occurs in Absence of Classical Apoptotic Events and Induces Eryptosis of Parasitized Host Cells

Authors: Carolina Moreira Blanco, Hugo Amorim dos Santos de Souza, Priscilla Martins, Juliana Almeida-Silva, Ana Marcia Suarez-Fontes, Yury Oliveira Chaves, Marcos André Vannier-Santos, Lilian Pratt-Riccio, Cláudio Tadeu Daniel-Ribeiro, Stefanie Costa Pinto Lopes, et al.

Year: 2024

Journal: Pathogens